Year
2023
-
Cognition Therapeutics and ACTC Receive FDA Clearance for Phase 2 START Study of Oral CT1812 in Early Alzheimer’s Disease
-
FDA Approves Austedo XR Extended-Release Tablets for Huntington’s Disease
-
Title: Protecting COPD Patients: Theravance and Viatris Aim to Prevent Generic Versions of Vital Drug
-
EU Authorizes CSL’s Gene Therapy for Hemophilia B
-
Alzheimer’s Antibody Therapy from Eli Lilly Granted US FDA Breakthrough Therapy designation
-
FDA creates task force to fast track COVID-19 drugs registration
-
Macrocyclic Peptidomestics Library Design and Synthesis
-
Design of Three-Dimensional Core Building Blocks adapted for DECL-Synthesis
-
First Principle Concept in Designing Small Molecules for Targeting RNA Expansion Repeats
-
a-Helix 3 D-Mimetics Library